ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $486 | -74.1% | 3,685 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $1,879 | -19.1% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,322 | -63.4% | 3,685 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $6,338 | +5.6% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | +20.0% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | +150.0% | 3,685 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $2,000 | -50.0% | 3,685 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $4,000 | -42.9% | 3,685 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $7,000 | -12.5% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | -38.5% | 3,685 | 0.0% | 0.00% | -55.6% |
| Q1 2021 | $13,000 | +44.4% | 3,685 | 0.0% | 0.01% | +28.6% |
| Q4 2020 | $9,000 | 0.0% | 3,685 | 0.0% | 0.01% | -22.2% |
| Q1 2020 | $9,000 | – | 3,685 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |